Domine Gomez, Manuel manuel.domine@uam.es

Actividades

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase II IMPULSE study

  • Thomas M, Ponce-Aix S, Navarro A, Riera-Knorrenschild J, Schmidt M, Wiegert E, Kapp K, Wittig B, Mauri C, Dómine Gómez M, Kollmeier J, Sadjadian P, Fröhling KP, Huber RM, Wolf M, IMPULSE study team

Annals Of Oncology (p. 2076-2084) - 1/10/2018

10.1093/annonc/mdy326 Ver en origen

  • ISSN 09237534

Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program

  • J Corral
  • Margarita Majem
  • Delvys Rodríguez Abreu
  • Enric Carcereny Costa
  • Ángel Artal Cortés
  • M Llorente
  • José María López-Picazo González
  • Yolanda García García
  • Manuel Dómine Gómez
  • M P López Criado
... Ver más Contraer

Clinical & Translational Oncology (p. 1270-1279) - 1/1/2019

  • ISSN 1699048X
  • iMarina

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: A phase Ib/randomized phase II trial

  • Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, Lowczak A, Aljumaily R, Rocha Lima CM, Boccia RV, Hanna W, Nikolinakos P, Chiu VK, Owonikoko TK, Schuster SR, Hussein MA, Richards DA, Sawrycki P, Bulat I, Hamm JT, Hart LL, Adler S, Antal JM, Lai AY, Sorrentino JA, Yang Z, Malik RK, Morris SR, Roberts PJ, Dragnev KH, G1T28-02 Study Group

Annals Of Oncology (p. 1613-1621) - 1/10/2019

10.1093/annonc/mdz278 Ver en origen

  • ISSN 09237534

Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer

  • Levy, B.P.
  • Giaccone, G.
  • Besse, B.
  • Felip, E.
  • Garassino, M.C.
  • Domine Gomez, M.
  • Garrido, P.
  • Piperdi, B.
  • Ponce-Aix, S.
  • Menezes, D.
  • MacBeth, K.J.
  • Risueño, A.
  • Slepetis, R.
  • Wu, X.
  • Fandi, A.
  • Paz-Ares, L.
... Ver más Contraer

European Journal Of Cancer (p. 120-128) - 1/2/2019

Editor: Elsevier Ltd

10.1016/j.ejca.2018.11.028 Ver en origen

  • ISSN 09598049
  • ISSN/ISBN 1879-0852

SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)

  • Dómine Gómez, Manuel
  • Morán Bueno, Teresa
  • Isla Casado, Dolores
  • Martí, J L
  • Sullivan, Ivana
  • Provencio Pulla, Mariano
  • Olmedo García, María Eugenia
  • Ponce Aix, Santiago
  • Blasco Cordellat, Ana
  • Cobo Dols, Manuel
... Ver más Contraer

Clinical & Translational Oncology (p. 245-255) - 1/2/2020

10.1007/s12094-020-02295-w Ver en origen

  • ISSN 1699048X

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

  • Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüro?lu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Ka?arnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L, CASPIAN investigators

Lancet Oncology (p. 51-65) - 1/1/2021

10.1016/s1470-2045(20)30539-8 Ver en origen

  • ISSN 14702045

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

  • Laza-Briviesca, Raquel
  • Cruz-Bermudez, Alberto
  • Nadal, Ernest
  • Insa, Amelia
  • Garcia-Campelo, Maria del Rosario
  • Huidobro, Gerardo
  • Domine, Manuel
  • Majem, Margarita
  • Rodriguez-Abreu, Delvys
  • Martinez-Marti, Alex
  • De Castro Carpeno, Javier
  • Cobo, Manuel
  • Lopez Vivanco, Guillermo
  • Del Barco, Edel
  • Bernabe Caro, Reyes
  • Vinolas, Nuria
  • Barneto Aranda, Isidoro
  • Viteri, Santiago
  • Massuti, Bartomeu
  • Casarrubios, Marta
  • Sierra-Rodero, Belen
  • Tarin, Carlos
  • Garcia-Grande, Aranzazu
  • Haymaker, Cara
  • Wistuba, Ignacio I.
  • Romero, Atocha
  • Franco, Fernando
  • Provencio, Mariano;
... Ver más Contraer

Clinical And Translational Medicine - 1/7/2021

10.1002/ctm2.491 Ver en origen

  • ISSN 20011326

NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

  • Sanchez-Herrero, Estela
  • Serna-Blasco, Roberto
  • Ivanchuk, Vadym
  • Garcia-Campelo, Rosario
  • Gomez, Manuel Domine
  • Sanchez, Jose M.
  • Massuti, Bartomeu
  • Reguart, Noemi
  • Camps, Carlos
  • Sanz-Moreno, Sandra
  • Calabuig-Farinas, Silvia
  • Jantus-Lewintre, Eloisa
  • Arnal, Magdalena
  • Fernandez-Orth, Dietmar
  • Calvo, Virginia
  • Gonzalez-Rumayor, Victor
  • Provencio, Mariano
  • Romero, Atocha;
... Ver más Contraer

Molecular Oncology (p. 2363-2376) - 1/9/2021

10.1002/1878-0261.13033 Ver en origen

  • ISSN 15747891

Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

  • de la Rosa, CA
  • Castellanos, PC
  • Lazaro-Quintela, M
  • Domine, M
  • Estevez, SV
  • Lopez-Vivanco, G
  • Perez, JLF
  • Romero, JLA
  • Delgado, LF
  • Giron, CG
  • Tain, PD
  • Alvarez, RA
  • Sanchis, PM
  • Canton, IF
  • Abos, IM
  • Aguillo, MM
  • Gutierrez, LGA
  • Granados, ALO
  • Cabellos, RA
  • Sebastian, AG
  • Sifuentes, LFG
  • Reguart, N
... Ver más Contraer

Lung Cancer (p. 83-93) - 1/11/2022

10.1016/j.lungcan.2022.09.010 Ver en origen

  • ISSN 01695002

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

  • Provencio M
  • Cobo M
  • Rodriguez-Abreu D
  • Calvo V
  • Carcereny E
  • Cantero A
  • Bernabé R
  • Benitez G
  • Castro RL
  • Massutí B
  • del Barco E
  • García Campelo R
  • Guirado M
  • Camps C
  • Ortega AL
  • González Larriba JL
  • Sánchez A
  • Casal J
  • Sala MA
  • Juan-Vidal O
  • Bosch-Barrera J
  • Oramas J
  • Dómine M
  • Trigo JM
  • Blanco R
  • Calzas J
  • Morilla I
  • Padilla A
  • Pimentao J
  • Sousa PA
  • Torrente M
... Ver más Contraer

Bmc Cancer - 1/12/2022

10.1186/s12885-022-09830-8 Ver en origen

  • ISSN 14712407

Cáncer de pulmón de célula pequeña

  • Manuel Dómine Gómez
  • Pilar Garrido López

1/1/2006

Editor: Madrid : Editores Médicos, 2006

  • ISBN 8477142416
  • ISSN/ISBN 84-7714-241-6

Este/a investigador/a no tiene capítulos de libro.

Este/a investigador/a no tiene congresos.

Este/a investigador/a no tiene documentos de trabajo.

Este/a investigador/a no tiene informes técnicos.

Este/a investigador/a no tiene proyectos de investigación.

Este/a investigador/a no tiene tesis dirigidas.

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 21/09/23 14:03